Business Context and Reporting Period
This Form 8-K is a current report filed by LabStyle Innovations Corp. (not Dariohealth Corp.) on June 3, 2016, regarding events occurring on May 31, 2016. The company is incorporated in Delaware and maintains its principal executive offices in Caesarea Industrial Park, Israel.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial performance data.
Material Changes
The primary material change reported is the appointment of Mr. Yalon Farhi as a member of the Board of Directors to fill a vacancy. His appointment took effect on June 1, 2016. Mr. Farhi was nominated by Shmuel Farhi, a significant stockholder of the Company.
Management Commentary and Risks
- Director Background: Mr. Farhi, age 54, is a Colonel in the Israeli Defense Forces (reserves). His background includes serving as a motivational lecturer, an administrative manager for a non-governmental organization, a private security consultant, and the owner of a gardening and land development services company for thirty years.
- Qualifications: The Company believes Mr. Farhi is qualified to serve on the Board due to his business experience.
- Compensation: As a director, Mr. Farhi is entitled to participate in the Company's applicable director compensation arrangements as described in the 2015 Form 10-K. He is not currently assigned to any Board committees.
Investor Verification Checklist
- Verify the correct registrant name is LabStyle Innovations Corp., not Dariohealth Corp.
- Confirm the effective date of the new director's appointment (June 1, 2016).
- Review the Company's 2015 Form 10-K, Item 11, for details on director compensation arrangements applicable to Mr. Farhi.
- Assess the relationship between the new director and the significant stockholder, Shmuel Farhi, who suggested the nomination.